We manufacture only the highest quality biopharmaceutical products – antibodies, cell & gene therapies, proteins, and vaccines – for our partners
Quality control testing
cGMP manufacturing of bulk drug substances
Development, scale-up, and production
Proprietary platform technologies
Partnering and Licensing
Ology Bio uses the Vero Cell vaccine manufacturing cell line developed by and acquired from Baxalta/Baxter Vaccines. This platform has demonstrated value for the rapid development of inactivated whole virus vaccines. Licenses to this technology are available for specific indications and markets worldwide.
Vero Cells (DMF 10336, Master and Working Cell banks) – optimized for production of vaccines
Fully Characterized – With a successful track record
Licensed – in the EU, US, Australia, New Zealand and Brazil
Suitable for production – all types of viral vaccines
Ology Bio is a fully integrated company in which product development programs are matrix-managed collaborations, with a Principal Investigator (PI) and a Project Manager (PM) assigned to each goal along with the related internal staff, subcontractor PIs and personnel, and consultants.